Literature DB >> 26122865

How close are we to a pharmacogenomic test for clozapine-induced agranulocytosis?

Moira Verbelen1, Cathryn M Lewis1,2.   

Abstract

Entities:  

Keywords:  HLA; agranulocytosis; clozapine; pharmacogenomic testing

Mesh：

Substances：

Year:  2015        PMID： 26122865     DOI： 10.2217/pgs.15.67

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  3 in total

1.  Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population.

Authors:  K van der Weide; H Loovers; K Pondman; J Bogers; T van der Straaten; E Langemeijer; D Cohen; J Commandeur; J van der Weide
Journal:  Pharmacogenomics J       Date:  2016-05-10       Impact factor: 3.550

2.  Psychiatric Pharmacogenomics: How Close Are We?

Authors:  Matthew E Hirschtritt; Aaron D Besterman; David A Ross
Journal:  Biol Psychiatry       Date:  2016-08-11       Impact factor: 13.382

3.  Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.

Authors:  Oddur Ingimarsson; James H MacCabe; Magnús Haraldsson; Halldóra Jónsdóttir; Engilbert Sigurdsson
Journal:  BMC Psychiatry       Date:  2016-12-12       Impact factor: 3.630
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.